This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Iacoviello, L. Articles by Donati, M. B. Search for Related Content Social Bookmarking                         What's this?

Review: The genetics of macrovascular disease in diabetes

'Angela Valenti' Laboratory of Genetic and Environmental Risk Factors for Thrombotic Disease, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy, iaco{at}cmns.mnegri.it

Elisabetta Ciccarone

'Angela Valenti' Laboratory of Genetic and Environmental Risk Factors for Thrombotic Disease, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy, Department of Medicine and Ageing, University of Chieti, Chieti, Italy

Maria Benedetta Donati

Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Patients with diabetes mellitus show an increased risk of developing macrovascular disease. Although common cardiovascular risk factors are abnormally high in patients with type 2 diabetes compared to the general population, they cannot fully explain the high rate of vascular complications. Indeed the occurrence and the severity of such complications are highly heterogeneous even in patients with comparable levels of glycaemic control and similar prevalence of cardiovascular risk factors. Large-vessel atherosclerosis can precede the clinical manifestation of diabetes. This suggests that both atherosclerosis and type 2 diabetes may have common genetic and environmental antecedents. A large body of evidence supports the possible role of genetics in determining the expression of the ischaemic vascular phenotype in diabetic patients, mainly derived from studies in ethnic groups or in first-degree relatives of diabetic patients and from association studies with genetic polymorphisms. Unravelling the polygenic susceptibility factors for macrovascular complications of diabetes is difficult, since diabetes per se has multifactorial inheritance. Direct evidence is largely based on the candidate gene approach in case-control studies. Several systems provide candidate genes that could by themselves or by interacting with other factors, increase the risk of ischaemic vascular disease in diabetic patients mainly related to lipid metabolism, lipoprotein oxidation and haemostatic processes.

Key Words: type 2 diabetes • macrovascular complications • genetics • polymorphisms • common soil hypothesis.

References

• Howard BV, Rodriguez BL, Bennett PH et al. Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology. Circulation 2002;105:e132-7.[CrossRef][Medline] [Order article via Infotrieve]
• Stern MP Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med 1996;124:110-16.[Abstract/Free Full Text]
• Eckel RH, Wassef M., Chait A. et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation 2002;105:e138-43.[CrossRef][Medline] [Order article via Infotrieve]
• Nelson RG, Sievers ML, Knowler WC et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 1990;81:987-95.[Abstract/Free Full Text]
• Howard BV, Lee ET, Fabsitz RR et al. Diabetes and coronary heart disease in American Indians: The Strong Heart Study. Diabetes 1996;45(suppl 3):S6-13.[Web of Science][Medline] [Order article via Infotrieve]
• Mitchell BD, Hazuda HP, Haffner SM, Patterson JK, Stern MP Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. Circulation 1991;83:45-51.[Abstract/Free Full Text]
• Krolewski AS, Czyzyk A., Kopczynski J., Rywik S. Prevalence of diabetes mellitus, coronary heart disease and hypertension in the families of insulin dependent and insulin independent diabetics. Diabetologia 1981;21:520-4.[Web of Science][Medline] [Order article via Infotrieve]
• Stewart MW, Humphriss DB, Berrish TS et al. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 1995;18:1020-2.[Abstract]
• Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, Ferrannini E. Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 1989;9:928-33.[Abstract/Free Full Text]
• Mansfield MW, Heywood DM, Grant PJ Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 1996;94: 2171-6.[Abstract/Free Full Text]
• Gurlek A., Bayraktar M., Kirazli S. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels. Diabetes Care 2000;23:88-92.[Abstract]
• Mansfield MW, Kohler HP, Ariens RA, McCormack LJ, Grant PJ Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care 2000;23:703-05.[Free Full Text]
• Iacoviello L., Zito F., Di Castelnuovo A., de Maat M., Kluft C., Donati MB The contribution of Fibrinogen, Fibrinolytic components and Factor VII to the risk of cardiovascular disease: their genetic determinants. Fibrinol Proteol 1998;12:259-76.[CrossRef]
• Semenkovich CF, Heinecke JW The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes 1997;46:327-34.[Abstract]
• Barakat K., Hitman GA Genetic susceptibility to macrovascular complications of type 2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2001;15:359-70.[CrossRef][Medline] [Order article via Infotrieve]
• Ukkola O., Savolainen MJ, Salmela PI, von Dickhoff K., Kesaniemi YA DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. Atherosclerosis 1995;115:99-105.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ukkola O., Savolainen MJ, Salmela PI, von Dickhoff K., Kesaniemi YA DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. Clin Genet 1994;46:217-27.[Web of Science][Medline] [Order article via Infotrieve]
• Kawasaki I., Tahara H., Emoto M., Shoji T., Nishizawa Y. Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes. Diabetes 2002;51:871-4.[Abstract/Free Full Text]
• Meguro S., Takei I., Murata M. et al. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis 2001;156:151-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Durlach A., Clavel C., Girard-Globa A., Durlach V. Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 1999;84:3656-9.[Abstract/Free Full Text]
• Ruiz J., Blanche H., James RW et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995;346: 869-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sakai T., Matsuura B., Onji M. Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus. Intern Med 1998;37:581-4.[Web of Science][Medline] [Order article via Infotrieve]
• Odawara M., Tachi Y., Yamashita K. Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulindependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:2257-60.[Abstract/Free Full Text]
• Osei-Hyiaman D., Hou L., Mengbai F., Zhiyin R., Zhiming Z., Kano K. Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism? Eur J Endocrinol 2001;144:639-44.[Abstract]
• Pfohl M., Koch M., Enderle MD et al. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes 1999;48:623-7.[Abstract]
• Aubo C., Senti M., Marrugat J. et al. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators. Eur Heart J 2000;21:33-8.[Abstract/Free Full Text]
• Garin MC, James RW, Dussoix P. et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 1997;99:62-6.[Web of Science][Medline] [Order article via Infotrieve]
• Leviev I., Negro F., James RW Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler Thromb Vasc Biol 1997;17:2935-9.[Abstract/Free Full Text]
• James RW, Leviev I., Ruiz J., Passa P., Froguel P., Garin MC Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 2000;49: 1390-3.[Abstract]
• Carter AM, Mansfield MW, Stickland MH, Grant PJ Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM. Diabetes Care 1996;19: 1265-8.[Abstract]
• Lam KS, Ma OC, Wat NM, Chan LC, Janus ED Beta-fibrinogen gene G/A 455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes. Diabetologia 1999;42:1250-3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mansfield MW, Stickland MH, Grant PJ Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995;74:1032-4.[Web of Science][Medline] [Order article via Infotrieve]
• Iacoviello L., Burzotta F., Di Castelnuovo A., Marchioli R., Donati MB The 4G/5G polymorphism of PAI-1 promoter gene as a risk factor for myocardial infarction: a meta-analysis. Thromb Haemost 1998;80:1029-30.[Web of Science][Medline] [Order article via Infotrieve]
• Mansfield MW, Stickland MH, Grant PJ Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995;74:1032-4.[Web of Science][Medline] [Order article via Infotrieve]
• Kimura H., Gejyo F., Suzuki Y., Suzuki S., Miyazaki R., Arakawa M. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1. Kidney Int 1998;54:1659-69.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 5, 364-368 (2002)
DOI: 10.1177/14746514020020050401


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Iacoviello, L. Articles by Donati, M. B. Search for Related Content Social Bookmarking                         What's this?